Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Carbohydrates, glycemic index and diabetes mellitus

Continuous glucose monitoring in children with glycogen storage disease type I

European Journal of Clinical Nutrition volume 68, pages 101–105 (2014)Cite this article

Subjects

Abstract

Background/Objectives:

Glycogen storage disease type I (GSD I) is an autosomal recessive metabolic disorder caused by defects in the glucose-6-phosphatase complex. Deficient activity in the glucose-6-phosphatase-α catalytic unit characterizes GSD Ia and defects in the glucose-6-phosphate transporter protein characterize GSD Ib. Type Ia involves the liver, kidney and intestine (and Ib also leukocytes), and the clinical manifestations are hepatomegaly, failure to thrive, severe fasting hypoglycemia within 3-4 h after a meal, hyperlactatemia, hyperuricemia and hyperlipidemia. The aim of the present study was to examine the safety and efficacy of a continuous subcutaneous glucose monitoring system to determine the magnitude and significance of hypoglycemia in GSD I and to evaluate the efficacy of the revised dietary treatment.

Subjects/Methods:

Sixteen children with GSD I were studied over a 72-h period. Continuous glucose monitoring (CGM) was repeated in all patients 3–6 months after the first monitoring to examine the effects of revised dietary instructions on glycemic control.

Results:

All the patients completed the study without any major adverse events. Significant periods of asymptomatic hypoglycemia (below 4 mmol/l, 70 mg/dl) were noted. There was a close correlation between CGM sensor and capillary blood glucose values measured by a glucometer. CGM indicated a considerable reduction in duration of hypoglycemia, liver size and improvements in secondary metabolic derangements such as hyperlacticacidemia and hyperlipidemia.

Conclusions:

CGM could be applied in the clinical setting to help the physician to identify hypoglycemic events, and repeated CGM may serve as a safe and useful tool for the assessment of the long-term management of patients with GSD I.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Bhattacharya K . Dietary dilemmas in the management of glycogen storage disease type I. J Inherit Metab Dis 2011; 34: 621–629.

    Article  CAS  Google Scholar 

  2. Chou JY, Jun HS, Mansfield BC . Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy. Nat Rev Endocrinol 2010; 6: 676–688.

    Article  CAS  Google Scholar 

  3. Skyler JS . Intensive insulin therapy: a personal and historical perspective. Diabetes Educ 1989; 15: 33–39.

    Article  CAS  Google Scholar 

  4. Diabetes Research in Children Network (DirecNet) Study Group. The accuracy of the Guardian RT continuous glucose monitor in children with type 1 diabetes. Diabetes Technol Ther 2008; 10: 266–272.

    Article  Google Scholar 

  5. Hershkovitz E, Rachmel A, Ben-Zaken H, Phillip M . Continuous glucose monitoring in children with glycogen storage disease type I. J Inherit Metab Dis 2001; 24: 863–869.

    Article  CAS  Google Scholar 

  6. Jadviscokova T, Fajkusova Z, Pallayova M, Luza J, Kuzmina G . Occurence of adverse events due to continuous glucose monitoring. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007; 151: 263–266.

    Article  Google Scholar 

  7. Mastrototaro J, Welsh JB, Lee S . Practical considerations in the use of real-time continuous glucose monitoring alerts. J Diabetes Sci Technol 2010; 4: 733–739. (Review).

    Article  Google Scholar 

  8. Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Çalikoglu AS . Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes 2006; 7: 159–164.

    Article  Google Scholar 

  9. Maran A, Crepaldi C, Avogaro A, Catuogno S, Burlina A, Poscia A et al. Continuous glucose monitoring in conditions other than diabetes. Diabetes Metab Res Rev 2004; 20 (Suppl 2), S50–S55.

    Article  Google Scholar 

  10. Mastrototaro J, Shin J, Marcus A, Sulur G . STAR 1 Clinical Trial Investigators. Clinical Trial Investigators. The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes. Diabetes Technol Ther 2008; 10: 385–390.

    Article  CAS  Google Scholar 

  11. White FJ, Jones SA . The use of continuous glucose monitoring in the practical management of glycogen storage disorders. J Inherit Metab Dis 2011; 34: 631–642.

    Article  CAS  Google Scholar 

  12. Radermecker RP, Saint Remy A, Scheen AJ, Bringer J, Renard E . Continuous glucose monitoring reduces both hypoglycaemia and HbA1c in hypoglycaemia-prone type 1 diabetic patients treated with a portable pump. Diabetes Metab 2010; 36: 409–413.

    Article  CAS  Google Scholar 

  13. Ulf S, Ragnar H, Arne WP, Johnny L . Do high blood glucose peaks contribute to higher HbA1c? Results from repeated continuous glucose measurements in children. World J Pediatr 2008; 4: 215–221.

    Article  Google Scholar 

  14. Keenan DB, Cartaya R, Mastrototaro JJ . Accuracy of a new real-time continuous glucose monitoring algorithm. J Diabetes Sci Technol 2010; 4: 111–118.

    Article  Google Scholar 

  15. Battelino T, Bolinder J . Clinical use of real-time continuous glucose monitoring. Curr Diabetes Rev 2008; 4: 218–222. (Review).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Metabolism, Gazi University Hospital, Ankara, Turkey

    Ç S Kasapkara, G Cinasal Demir, A Hasanoğlu & L Tümer

Authors
  1. Ç S Kasapkara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Cinasal Demir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Hasanoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Tümer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ç S Kasapkara.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kasapkara, Ç., Cinasal Demir, G., Hasanoğlu, A. et al. Continuous glucose monitoring in children with glycogen storage disease type I. Eur J Clin Nutr 68, 101–105 (2014). https://doi.org/10.1038/ejcn.2013.186

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2013.186

Keywords

This article is cited by

Search

Advanced search

Quick links